News

Discover BIOLASE's Innovative Laser Solutions for Dentists

Discover BIOLASE's Innovative Laser Solutions for Dentists

Innovations in Dental Laser Technology

BIOLASE, recognized as the global leader in dental lasers, is set to showcase its advanced YSGG laser solutions at the 2025 Greater New York Dental Meeting (GNYDM). This significant event, occurring from November 28 to December 3, will highlight the critical advancements in periodontal and implant care, emphasizing the integration of laser solutions into modern dental practices.

Key Lecture on Laser Solutions

As part of their participation, BIOLASE will host a noteworthy lecture led by Dr. Philip Kang, DDS. The session, titled "Advancing Laser Solutions for Periodontal and Implant Health," is scheduled for Sunday, where attendees will gain insights into how Er,Cr:YSGG laser technology enhances clinical outcomes and patient experiences. This presentation will also inform dental professionals about practices that encourage practice growth through innovative technology.

Learning Objectives

During the presentation, Dr. Kang will outline a series of key learning objectives designed to empower dental professionals:

  • Understand the principles of Er,Cr:YSGG laser technology and how it operates.
  • Identify the clinical advantages that YSGG lasers bring to periodontal and implant procedures.
  • Recognize the improvements in patient comfort, efficiency, and overall outcomes with the use of YSGG lasers.
  • Evaluate ways in which laser technology can support the expansion of dental practices and introduce new service offerings.

A Statement from BIOLASE Leadership

Dr. Kwang Bum Park, the CEO of BIOLASE, expressed enthusiasm for the upcoming presentation, stating, "Laser dentistry continues to redefine modern periodontal and implant care. We are excited to demonstrate how our YSGG technology fosters predictable, comfortable, and minimally invasive treatment options for both clinicians and patients." This dedication not only underlines BIOLASE's commitment to excellence but also its focus on enhancing the overall patient experience.

Visit BIOLASE at GNYDM

Attendees at the GNYDM are encouraged to visit BIOLASE Booth #4129 for exclusive show pricing and to experience hands-on demonstrations of the Waterlase iPlus. The booth will provide live laser demonstrations, allow for clinical discussions, and offer opportunities to engage with BIOLASE specialists regarding the integration of all-tissue laser technology into everyday practice.

About BIOLASE

Operating with a legacy of over thirty years, BIOLASE has consistently pushed the boundaries of dental laser technology, creating high-performance laser systems that advance dentistry and significantly improve patient experiences. Their continued innovation stresses the importance of minimally invasive techniques, making dental procedures more efficient and less intimidating for patients.

Stay Connected with BIOLASE

For the latest updates and information on BIOLASE and their revolutionary advances in laser dentistry, you can find BIOLASE online and across social media platforms to stay in touch with ongoing developments.

Frequently Asked Questions

What is the main focus of BIOLASE at the GNYDM?

BIOLASE will showcase its innovative YSGG laser technologies aimed at improving periodontal and implant care.

Who will be presenting at the event?

Dr. Philip Kang, DDS, will lead a presentation focused on advancing laser solutions for dental health.

What are YSGG lasers?

YSGG lasers are advanced laser systems that enhance the effectiveness of various dental procedures by improving patient comfort and clinical outcomes.

How can dental professionals benefit from attending this presentation?

Participants will gain insights into the latest techniques and technologies that can be implemented in their practices to improve patient care.

How long has BIOLASE been in operation?

BIOLASE has over three decades of experience in the field of dental laser technology.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Prix Galien Nominations Spotlight Global Healing

Updated Category News Views 62

Beyond the Hype: Innovating for Healthier Tomorrows Kicking off in Stockholm on December 1st, the 2026 Prix Galien Bridges Awards isn't just some schmooze-fest; it's a hard-hitting showcase of where true innovation can propel healthcare. Over at the Karolinska Institutet, the Galien Foundation is drawing powerhouses from across the Nordics+ region and showcasing...

Continue Reading
Cell Counting Market Growth: USD 17.71 Billion by 2031

Updated Category News Views 199

The Cell Counting Surge: Money Talks in Science You can't deny it when the numbers speak—a jump from USD 12.39 billion to USD 17.71 billion by 2031 in the cell counting market means something ain't business as usual. That's a robust 7.40% CAGR folks; it's a field being bombarded with innovation. The spark? Automated and advanced cell analysis technology taking the...

Continue Reading
TransDigm Surges Ahead with Strong Q4 and FY Results

Updated Category News Views 87

TransDigm's Impressive Performance in Fiscal 2026 Here's a company that's really kicking it up a notch—TransDigm Group (NYSE:TDG) just reported some solid fourth-quarter numbers that scream growth. Net sales soared to $2,988 million, marking a 23% hike from last year's fourth quarter of $2,437 million. That's a cool $551 million leap, quite the party for shareholders....

Continue Reading
Braemar's $358 Million Refinance: A Strategic Shift

Updated Category News Views 67

Reworking the Debt Load: Braemar's New Move Most days, when a company decides to tinker with its debt, it's like watching paint dry for investors. But with Braemar Hotels & Resorts (NYSE: BHR) announcing a $358 million refinancing package, they're bringing a fresh breath of air to the table. Lemme walk you through why this matters beyond the glossy façade of luxury hotel...

Continue Reading
PC Richard & Son Offers Big Black Friday Savings

Updated Category News Views 96

Holiday Prep Kicks Into High Gear As November ticks on, folks are diving headfirst into the frenzy of holiday planning and spending. What better time for a salvo of sales from P.C. Richard & Son? The appliance stalwart is throwing down the gauntlet with hefty discounts and some intriguing offers on TVs, mattresses, and more. With Black Friday looming, the savvy shopper...

Continue Reading
Fake Profiles Dominate Daters' Trust Issues Today

Updated Category News Views 211

Trust Erosion in the Digital Dating Arena When it comes to modern dating, we're not talking hearts and flowers anymore; it's more like an elaborate game of detective work. A recent survey from Stud or Dud highlights the harsh reality that blind trust in digital dating profiles is about as outdated as sending a singing telegram. Almost half of the respondents pinned fake...

Continue Reading
Hi Peach Layne Rides Trend with New Hair Repair Oil

Updated Category News Views 45

Diving into Beauty Economics with Walmart Now here's a story that ticks every box in the bargain bin playbook—Hi Peach Layne's latest move into the haircare aisle. They're launching a Hair Repair Oil loaded with claims that shout 'value!' loud enough to echo down a Walmart aisle. With a price point of $9.97, it's sliding right into Walmart's "Beauty Finds Under $10"...

Continue Reading
Thesis Elements Expands Portfolio with Mappify Buy

Updated Category News Views 32

Mappify Acquisition: A Smooth Move for Higher Ed Picture a college student trying to juggle classes, work, and life like it's a circus act. That's not too far off from reality, and it's where Thesis America and its new acquisition, Mappify, come into play. By scooping up Mappify, Thesis aims to untangle this scheduling chaos for students across the board. From Data to...

Continue Reading
The DOG CATCHER: A New Spin on Pet Waste Cleanup

Updated Category News Views 43

Revolutionizing the Dreaded Pet Waste Duty Folks, here's a little dose of innovation from the streets of Baltimore: a gadget called the DOG CATCHER. No, it’s not about catching stray dogs, but dealing with their unpleasant leavings. This invention's got a patent pending and all, promising to make the nasty business of dog waste collection a whole lot less disgusting. I...

Continue Reading
Envista's $430M Senior Notes: A Market Move Decoded

Updated Category News Views 114

Envista on the Move with $430M Notes Ever feel like the market's a bit like a rollercoaster with no brakes? That's kind of where we're at with Envista Holdings Corporation (NYSE: NVST) rolling out this new financial play. They just priced a hefty $430 million in Senior Notes at a solid 6.250% due 2033. In terms of the investment world, that's a pretty big splash. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Asieris Pharmaceuticals Reveals Exciting Cevira Study Insights

Updated Category News Views 107

Asieris Pharmaceuticals dropped some heavy news back in 2024 about its Phase III study for Cevira (APL-1702), a drug aiming to tackle cervical High-Grade Squamous Intraepithelial Lesion (HSIL). This ain’t just another clinical trial; it’s a serious play against HPV, and the desks are buzzing with implications. So, what’s the deal? Traders were tuning in hard after...

Continue Reading
Synchronoss Technologies Schedules Q1 2025 Earnings Call

Updated Category News Views 132

Synchronoss Technologies Schedules First Quarter Earnings Call BRIDGEWATER, N.J. — Synchronoss Technologies Inc. (Nasdaq: SNCR), a prominent innovator in Personal Cloud platforms, is gearing up for its upcoming conference call. Details of the Earnings Call This important event is set to take place on a Tuesday in May at 4:30 p.m. Eastern time, following the company’s...

Continue Reading
Perma-Fix Environmental Services Conference Call Scheduled

Updated Category News Views 126

Perma-Fix Announces Upcoming Business Update Conference Call Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) has exciting plans for its investors. The Company has announced that it will host a business update conference call, set for 11:00 AM Eastern Time on an upcoming Wednesday. This event is significant as it offers an opportunity for investors and interested...

Continue Reading
Atos Group's 2025 Liquidity Position: Insights and Updates

Updated Category News Views 549

Understanding Atos Group's 2025 Liquid Position Atos Group recently shared its anticipated liquidity position for the first half of 2025, providing crucial insights into its financial health. As a major player in digital transformation, the company aims to maintain transparency in its financial reporting, particularly to its stakeholders. Liquidity Insights and Financial...

Continue Reading
Investigation into Shareholder Rights for BCOV, ENLC, CCRN

Updated Category News Views 173

Investigation into Shareholder Rights Halper Sadeh LLC, a prominent law firm focused on investor rights, is engaging in a comprehensive investigation regarding several companies regarding potential violations of federal securities laws and fiduciary duties to shareholders. Brightcove Inc. and Its Recent Sale Brightcove Inc. (NASDAQ: BCOV) has announced a sale to Bending...

Continue Reading